Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Carnevale-Schianca

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Opinion on Biological Therapy|July 22, 2017
Treating breast cancer with cell-based approaches: an overviewSusanna Gallo, Dario Sangiolo, Fabrizio Carnevale Schianca, et al.
Cancers|January 11, 2024
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future PerspectiveStefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
BMC Cancer|April 15, 2017
Alpha-fetoprotein elevation in NUT midline carcinoma: a case reportLorenzo D'Ambrosio, Erica Palesandro, Marina Moretti, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Role of interferon in melanoma: old hopes and new perspectivesMartina Sanlorenzo, Igor Vujic, Fabrizio Carnevale-Schianca, et al.
BMC Cancer|October 14, 2016
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case reportElisabetta Fenocchio, Ilaria Depetris, Delia Campanella, et al.
Expert Opinion on Biological Therapy|July 25, 2015
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectivesMartina Sanlorenzo, Igor Vujic, Adrian Moy, et al.
Immunotherapy|July 17, 2018
Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effectPaola Circosta, Katia Vitaggio, Angela Rita Elia, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Opinion on Biological Therapy|July 22, 2017
Treating breast cancer with cell-based approaches: an overviewSusanna Gallo, Dario Sangiolo, Fabrizio Carnevale Schianca, et al.
Cancers|January 11, 2024
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future PerspectiveStefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
BMC Cancer|April 15, 2017
Alpha-fetoprotein elevation in NUT midline carcinoma: a case reportLorenzo D'Ambrosio, Erica Palesandro, Marina Moretti, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Role of interferon in melanoma: old hopes and new perspectivesMartina Sanlorenzo, Igor Vujic, Fabrizio Carnevale-Schianca, et al.
BMC Cancer|October 14, 2016
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case reportElisabetta Fenocchio, Ilaria Depetris, Delia Campanella, et al.
Expert Opinion on Biological Therapy|July 25, 2015
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectivesMartina Sanlorenzo, Igor Vujic, Adrian Moy, et al.
Immunotherapy|July 17, 2018
Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effectPaola Circosta, Katia Vitaggio, Angela Rita Elia, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Pageof 5